Latest Regulatory News

Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.

DroneShield Limited has retracted its recent announcement of $7.6 million in new U.S. Government orders, clarifying these were reissued contracts rather than fresh deals. The company is addressing the administrative error to prevent future confusion.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

Critica Limited has demonstrated a 63% recovery of gallium oxide as a valuable by-product from its vast Jupiter rare earth deposit in Western Australia, integrating seamlessly into its existing beneficiation flowsheet. This milestone enhances the project’s strategic value amid global supply chain tensions.

Core Lithium has unveiled an updated mine plan for its Grants deposit at the Finniss Lithium Project, increasing the Ore Reserve by 33% and cutting pre-production capital costs by up to $45 million.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

AGL Energy has agreed to divest 19.9% of its 20% stake in Tilt Renewables for $750 million, reinforcing its strategy to recycle capital and invest in flexible energy capacity while maintaining a strategic partnership.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Ballard Mining Limited has released a comprehensive investor update following its July 2025 IPO, highlighting a robust 1.1 million ounce gold resource at Mt Ida and a strong cash position of $40 million. The company outlines ambitious exploration targets and development plans aiming to extend mine life beyond a decade.

New Frontier Minerals has secured regulatory approval to launch its first reverse circulation drilling campaign at the Harts Range Heavy Rare Earth and Niobium Project, while also preparing for a US OTCQB listing to broaden investor reach.